Skip to content
2000
Volume 22, Issue 4
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

Most of the newly discovered drug candidates are lipophilic and poorly water-soluble, making it a significant challenge for the pharmaceutical industry to formulate suitable drug delivery systems. This review gives insight into an overview of the liquisolid technique (LST) and summarizes the progress of its various applications in drug delivery. This novel technique involves converting liquid drugs or drugs in a liquid state (such as solutions, suspensions, or emulsions) into dry, non-adherent, free-flowing, and readily compressible powder mixtures by blending or spraying a liquid dispersion onto specific powder carriers and coating materials. In Liquisolid systems, the liquid medication is absorbed into the interior framework of carriers. Once the carrier's interior is saturated with liquid medication, a liquid layer forms on the surface of the carrier particles, which is instantly adsorbed by the fine coating material. As a result, a dry, free-flowing, and compressible powder mixture is formed. Compared to other solubility enhancement techniques, s.a. micronization, inclusion complexation, microencapsulation, nanosuspension, and self-nano emulsions, LST is relatively simple to prepare and may offer a cost-effective solution to enhance the solubility of poorly water-soluble drugs enhancing its bioavailability in drug formulation and delivery.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cddt/10.2174/0115701638318659240923074614
2024-10-04
2025-09-09

  • From This Site

    /content/journals/cddt/10.2174/0115701638318659240923074614
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PrustyA. Formulation and evaluation of ciprofloxacin colon targeted tablets by compression coating technique using guar gum and hydroxy propyl methylcellulose.J Res Pharm202226615931607
     [Google Scholar]
  2. PrustyA. Carobomer based controlled release designs of atorvastatin calcium tablets evaluated using quality by design (QbD) approach.Am. J. Anal. Chem.2017831991862
     [Google Scholar]
  3. Lachman lThe theory and practice of industrial pharmacy. Special indian edition.New DelhiCBS Publication & Distributors Pvt. Ltd.2009221
     [Google Scholar]
  4. SavkareA.D. BhavsarM.R. GholapV.D. KukkarP.M. Liquisolid technique: A review.Int. J. Pharm. Sci. Res.20178727682775
     [Google Scholar]
  5. GeethikaG. Compact Technology: A Review.Indo-American J Pharmaceut Sci201523684691
     [Google Scholar]
  6. GavaliS.M. Liquisolid compact: A New technique for dissolution enhancement.Int. J. Res. Pharm. Chem.201113705713
     [Google Scholar]
  7. KhaledK.A. AsiriY.A. El-SayedY.M. In vivo evaluation of liquisolid tablets in beagle dogs.Int. J. Pharm.20012221610.1016/S0378‑5173(01)00633‑0 11404027
     [Google Scholar]
  8. LuM. XingH. JiangJ. Liquisolid technique and its applications in pharmaceutics.Asian J. Pharmaceut Sci.201712211512310.1016/j.ajps.2016.09.007 32104320
     [Google Scholar]
  9. HussainY. CuiJ. DormocaraA. KhanH. The most recent advances in liquisolid technology: Perspectives in the pharmaceutical industry.Pharmaceut Sci Advances2024210003810.1016/j.pscia.2024.100038
     [Google Scholar]
  10. RashadA. LouisD. An overview on liquisolid technique: Its development and applications.Ther. Deliv.2022131257758910.4155/tde‑2022‑0057 36861309
     [Google Scholar]
  11. KesisoglouF. PanmaiS. WuY. Nanosizing — Oral formulation development and biopharmaceutical evaluation.Adv. Drug Deliv. Rev.200759763164410.1016/j.addr.2007.05.003 17601629
     [Google Scholar]
  12. SavićR. EisenbergA. MaysingerD. Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions.J. Drug Target.200614634335510.1080/10611860600874538 17092835
     [Google Scholar]
  13. AhujaN. KatareO.P. SinghB. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.Eur. J. Pharm. Biopharm.2007651263810.1016/j.ejpb.2006.07.007 16962750
     [Google Scholar]
  14. AmidonG.L. LennernäsH. ShahV.P. CrisonJ.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability.Pharm. Res.199512341342010.1023/A:1016212804288 7617530
     [Google Scholar]
  15. ChawdharyK.P.R. Biopharmaceutical classification system.Indian Pharmacist20042024710
     [Google Scholar]
  16. JaiswalS.B. Biopharmaceutics and pharmacokinetics: A treatise.Delhi, IndiaVallabh Prakashan2005
     [Google Scholar]
  17. AguiarA.J. Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt.J. Pharm. Sci.1967561243125210.1002/jps.2600561006 6059441
     [Google Scholar]
  18. FinholtP. SolvangS. Dissolution kinetics of drugs in human gastric juice--the role of surface tension.J. Pharm. Sci.19685781322132610.1002/jps.2600570809 5677333
     [Google Scholar]
  19. LinS.L. MenigJ. LachmanL. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs.J. Pharm. Sci.196857122143214810.1002/jps.2600571225 5708358
     [Google Scholar]
  20. SpireasS. SaduS. Enhancement of prednisolone dissolution properties using liquisolid compacts.Int. J. Pharm.1998166217718810.1016/S0378‑5173(98)00046‑5
     [Google Scholar]
  21. SpireasS. SaduS. GroverR. In vitro release evaluation of hydrocortisone liquisolid tablets.J. Pharm. Sci.199887786787210.1021/js970346g 9649356
     [Google Scholar]
  22. SpireasS. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts.Drug Dev. Ind. Pharm.19992563168
     [Google Scholar]
  23. YangK.Y. Effect of amorphous silicon dioxide on drug dissolution.J. Pharm. Sci.19796856056510.1002/jps.2600680511 219197
     [Google Scholar]
  24. LiaoC.C. JarowskiC.I. Dissolution rates of corticoid solutions dispersed on silicas.J. Pharm. Sci.198473340140310.1002/jps.2600730330 6325660
     [Google Scholar]
  25. SpireasS. Liquisolid systems and methods of preparing same. US Patent 6423339B12002,2002
     [Google Scholar]
  26. NokhodchiA. AliakbarR. DesaiS. JavadzadehY. Liquisolid compacts: The effect of cosolvent and HPMC on theophylline release.Colloids Surf. B Biointerfaces201079126226910.1016/j.colsurfb.2010.04.008 20451361
     [Google Scholar]
  27. SpireasS. Liquisolid systems and methods of preparing same. US Patent 5800834A1999.
  28. Fuji chemical industries Co., Ltd. We create safe and useful medicines. 2024. Available From: www.fujichemical.co.jp
  29. NaseemA. OlliffC.J. MartiniL.G. LloydA.W. Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin.Int. J. Pharm.2004269244345010.1016/j.ijpharm.2003.09.029 14706255
     [Google Scholar]
  30. GursoyR.N. SelfEmulsifying drug delivery systems (sedds) for improved oral delivery of lipophilic drug biomed.Pharmacotherapy20045817318210.1016/j.biopha.2004.02.001
     [Google Scholar]
  31. KapsiS.G. AyresJ.W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.Int. J. Pharm.20012291-219320310.1016/S0378‑5173(01)00867‑5 11604272
     [Google Scholar]
  32. SolvangS. FinholtP. Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice.J. Pharm. Sci.1970591495210.1002/jps.2600590106 5411324
     [Google Scholar]
  33. GraneroG.E. RamachandranC. AmidonG.L. Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions.Drug Dev. Ind. Pharm.200531991792210.1080/03639040500272108 16306004
     [Google Scholar]
  34. RasenackN. HartenhauerH. MüllerB.W. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs.Int. J. Pharm.2003254213714510.1016/S0378‑5173(03)00005‑X 12623189
     [Google Scholar]
  35. JavadzadehY. Enhancement of dissolution rate of piroxicam using liquisolid compacts.Farmaco200560361365
     [Google Scholar]
  36. NokhodchiA. JavadzadehY. Siahi-ShadbadM.R. Barzegar-JalaliM. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.J. Pharm. Pharm. Sci.2005811825 15946594
     [Google Scholar]
  37. FahmyR. KassemM. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: In vitro and in vivo evaluation.Eur. J. Pharm. Biopharm.2008693993100310.1016/j.ejpb.2008.02.017 18396390
     [Google Scholar]
  38. TiongN. ElkordyA.A. Effects of liquisolid formulations on dissolution of naproxen.Eur. J. Pharm. Biopharm.200973337338410.1016/j.ejpb.2009.08.002 19679184
     [Google Scholar]
  39. BoltonS. Sustainedrelease liquisolid compacts.25th International Symposium on Controlled Release of Bioactive Materials Nevada USA1389
     [Google Scholar]
  40. YadavV.B. Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique.J. Pharm. Sci.2009124451
     [Google Scholar]
  41. Al-ObaidiH. NokhodchiA. In vitro release of diltiazem HCl from liquisolid compacts.Drug Dev. Ind. Pharm.2017436937943
     [Google Scholar]
  42. BaertschiS.W. Pharmaceutical stress testing: Predicting drug degradation.2nd edBoca Raton, FloridaCRC Press2011
     [Google Scholar]
  43. BozdagS. OzerY. ErtanG. The effect of the type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.J. Pharm. Pharmacol.2010811825
     [Google Scholar]
  44. SinghS.K. SrinivasanK.K. GowthamarajanK. PrakashD. GaikwadN.B. SingareD.S. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.Drug Dev. Ind. Pharm.201238896197010.3109/03639045.2011.634810 22251080
     [Google Scholar]
  45. FaridR.M. KassemM.A. ElmeshadA.N. Optimization of glibenclamide liquisolid tablets via Box-Behnken design: Influence of formulation variables on dissolution.Eur. J. Pharm. Biopharm.2010762207213 21130874
     [Google Scholar]
  46. GhoshI. MukherjeeB. Fabrication of lecithin-based liquisolid systems for enhanced solubility and bioavailability of aceclofenac.J. Drug Deliv. Sci. Technol.201739405415
     [Google Scholar]
  47. JavadzadehY. MusaalrezaeiL. NokhodchiA. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.Int. J. Pharm.20083621-210210810.1016/j.ijpharm.2008.06.022 18647643
     [Google Scholar]
  48. KassemM.A. ElMeshadA.N. Liquisolid technique to enhance and sustain griseofulvin dissolution: Effect of choice of non-volatile liquid vehicles.Int. J. Pharm.20083611-28592
     [Google Scholar]
  49. SaeediM. AkbariJ. Morteza-SemnaniK. Enayati-FardR. Sar-Reshteh-DarS. SoleymaniA. Enhancement of dissolution rate of indomethacin: Using liquisolid compacts.Iran. J. Pharm. Res.20111012534 24363677
     [Google Scholar]
  50. LiuM.K. ChenH.L. ChenL.L. Andrographolide liquisolid using porous-starch as the adsorbent with enhanced oral bioavailability in rats.J. Pharm. Sci.2023112253554310.1016/j.xphs.2022.08.033 36058257
     [Google Scholar]
  51. TadrosM.I. FotuzyarS.S. NokhodchiA. Liquisolid technique as a tool for enhancing the dissolution and bioavailability of furosemide.AAPS PharmSciTech2010111355365
     [Google Scholar]
  52. AhmedT.A. AlotaibiH.A. AlharbiW.S. SafoM.K. El-SayK.M. Development of 3D-Printed, Liquisolid and directly compressed glimepiride tablets, loaded with black seed oil self-nanoemulsifying drug delivery system: In vitro and in vivo characterization.Pharmaceuticals (Basel)20221516810.3390/ph15010068 35056126
     [Google Scholar]
  53. YadavV.B. Enhancement of solubility and dissolution rate of BCS class II pharmaceuticals by nonaquious granulation technique.Int J Pharma Res2010121233
     [Google Scholar]
  54. KapureV.J. Dissolution enhancement of rosuvastatin calcium by liquisolid compact technique.J. Pharm. (Cairo)20132017315902
     [Google Scholar]
  55. KarmarkarA.B. GonjariI.D. HosmaniA.H. Liquisolid technology for dissolution rate enhancement or sustained release.Expert Opin. Drug Deliv.20107101227123410.1517/17425247.2010.511173 20731614
     [Google Scholar]
  56. TayelS.A. Improvement of Dissolution Properties of carbamazepine through application of the liquisolid technique.Eur. J. Pharm. Biopharm.20086934234710.1016/j.ejpb.2007.09.003 17949959
     [Google Scholar]
  57. YadavV.B. Liquisolid granulation technique for tablet manufacturing.An Overview J Pharm Res200924670674
     [Google Scholar]
  58. AkinladeB. ElkordyA.A. EssaE.A. ElhagarS. Liquisolid systems to improve the dissolution of furosemide.Sci. Pharm.201078232534410.3797/scipharm.0912‑23 21179350
     [Google Scholar]
  59. YadavV.B. Tablets. The theory and practice of industrial pharmacy.Bombay, IndiaVarghese Publishing House1987
     [Google Scholar]
  60. CraigD.Q.M. ReadingM. Pharmaceutical applications of DSC.Thermal analysis of pharmaceuticals.Boca Raton, USACRC Press20075399
     [Google Scholar]
  61. USP NF.The united states pharmacopoeia national formulary USP28 NF23 the united states pharmacopoeial convention canada.2005Available Fromhttps://archive.org/details/unitedstatesphar00unit
    [Google Scholar]
  62. British pharmacopoeia. The british pharmacopoeia the stationary office London. 2004. Available From: https://www.pharmacopoeia.com/
  63. SanjeevR.G. Formulation and characterization of atorvastatin calcium liquisolid compacts.Asian J. Pharm. Sci.2010525060
     [Google Scholar]
  64. SurtiN. PatelD.S. PipaliyaR.M. Liquisolid tablets for dissolution enhancement of a hypolipidemic drug.Indian J. Pharm. Sci.201577329029810.4103/0250‑474X.159618 26180274
     [Google Scholar]
  65. KhaledK.A. Formulation and evaluation of hydrochlorothiazide liquisolid tablets.Saudi Pharm. J.198863946
     [Google Scholar]
  66. SanjeevG. Liquisolid technique for enhancement of dissolution properties of bromhexine hydrochloride.Saudi Pharm. J.20092283
     [Google Scholar]
  67. SahilM. Liquisolid compact: A new technique for enhancement of drug dissolution.IJRPC2011135558
     [Google Scholar]
  68. CaraballoI. MarasiniN. JiangT. Liquisolid technology to improve the solubility and dissolution rate of loratadine.AAPS PharmSciTech201819270771610.1208/s12249‑017‑0934‑0
     [Google Scholar]
  69. BorkarR.M. JainA.S. NerkarP.P. Enhancement of dissolution rate of ezetimibe by liquisolid compact technique.Powder Technol.201425318419310.1016/j.powtec.2013.10.056
     [Google Scholar]
  70. AmmarH.O. GhorabM. MahmoudA.A. MakramT.S. Rapidly disintegrating tablets containing taste-masked microspheres for eradication of H. pylori: Preparation, in vitro and in vivo evaluation.Int. J. Pharm.20144721-227528310.1016/j.ijpharm.2014.06.046 24491528
     [Google Scholar]
  71. SunD.D. LeeP.I. Probing the in vitro dissolution behavior of highly water-soluble drugs from liquisolid compacts.Eur. J. Pharm. Sci.2012471506010.1016/j.ejps.2012.03.004
     [Google Scholar]
  72. SankaliaM.G. MashruR.C. SankaliaJ.M. SutariyaV.B. Stability improvement of aceclofenac liquisolid compact using adsorbents.AAPS PharmSciTech200781E1E910.1208/pt0801001
     [Google Scholar]
  73. JavadzadehY. Jafari-NavimipourB. NokhodchiA. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).Int. J. Pharm.20073411-2263410.1016/j.ijpharm.2007.03.034 17498898
     [Google Scholar]
  74. CetinE.M. YetisginA.A. ArpagH. YildizA. Formulation and in vitro evaluation of carvedilol liquisolid compacts using Aerosil® as a carrier.Int. J. Pharm. Investig.201882889410.4103/jphi.JPHI_30_18
     [Google Scholar]
  75. SinghA. JainA. ShrivastavaS.K. Development and evaluation of liquisolid compacts of glimepiride for improved dissolution.J. Pharm. Bioallied Sci.20124Suppl. 1S98S10010.4103/0975‑7406.94134
     [Google Scholar]
  76. HentzschelC.M. AlnaiefM. SmirnovaI. SakranA.M. LeopoldC.S. Development of liquisolid compacts with improved dissolution properties for the poorly water-soluble drug valsartan.Drug Dev. Ind. Pharm.201238101210121710.3109/03639045.2011.651836
     [Google Scholar]
  77. DakeG. DakeJ. SayyadF. Formulation and evaluation of liquisolid tablets of poorly water-soluble drug carvedilol.Int. J. Pharm. Investig.201222828810.4103/2230‑973X.104387
     [Google Scholar]
  78. BharadiaP.D. DeshpandeA.D. ChavhanS. Preparation and evaluation of liquisolid compacts of aceclofenac.Int. J. Pharm. Investig.201331394510.4103/2230‑973X.108930
     [Google Scholar]
  79. BarghelN. DaveV. PriyankaS. Enhanced dissolution rate of rosuvastatin calcium using liquisolid compact technique.J. Adv. Pharm. Technol. Res.20101335435710.4103/0110‑5558.72423 22247871
     [Google Scholar]
  80. DehghanM.H.G. JavadzadehY. Jafari-NavimipourB. Improvement of dissolution rate of indomethacin by liquisolid technique.Iran. J. Pharm. Res.201093243250 24363733
     [Google Scholar]
  81. SalujaA. YadavA.K. SachanM. Formulation and evaluation of liquisolid compacts for improved dissolution of simvastatin.Int. J. Pharm. Investig.20122315015610.4103/2230‑973X.104406 23373006
     [Google Scholar]
  82. KaroleS. JadhavK. KadamV. Evaluation of liquisolid technique for raloxifene hydrochloride.Res J Pharm Tech200922273276
     [Google Scholar]
  83. PatelA. ShahT. AminA. Improvement of dissolution rate of furosemide using liquisolid compacts.J. Adv. Pharm. Technol. Res.20112213914510.4103/2231‑4040.82951 22171298
     [Google Scholar]
/content/journals/cddt/10.2174/0115701638318659240923074614
Loading
Liquisolid Technique for Solubility Enhancement of Poorly Soluble Drug - A Brief Review
Current Drug Discovery Technologies 22, E15701638318659 (2025); https://doi.org/10.2174/0115701638318659240923074614
/content/journals/cddt/10.2174/0115701638318659240923074614
/content/journals/cddt/10.2174/0115701638318659240923074614
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): BCS classification; carrier materials; coating materials; dissolution enhancement; Liquisolid technique; poorly water-soluble drug

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test